[B lymphocytes: a new "target" in treatment for multiple sclerosis].
Hohlfeld
R
R
D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D018448:Models, Immunological; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology*
D000911:Antibodies, Monoclonal